Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
172.20
-11.70 (-6.36%)
Sep 10, 2026, 1:14 PM HKT

Duality Biotherapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Market Capitalization
16,63426,664--
Market Cap Growth
-53.09%---
Enterprise Value
13,56722,676--
Last Close Price
183.90298.20--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PS Ratio
17.1112.94--
PB Ratio
9.939.87--
P/TBV Ratio
9.959.89--
P/FCF Ratio
-130.88--
P/OCF Ratio
-123.14--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
13.9511.00--
EV/FCF Ratio
-111.30--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.260.060.000.00
Debt / EBITDA Ratio
---0.01
Debt / FCF Ratio
-0.820.020.01
Net Debt / Equity Ratio
-1.83-1.330.691.01
Net Debt / EBITDA Ratio
1.797.147.63-1.53
Net Debt / FCF Ratio
3.20-17.64-4.94-1.40
Asset Turnover
0.220.621.08-
Quick Ratio
1.853.520.480.50
Current Ratio
1.993.650.490.52
Return on Equity (ROE)
-65.93%-1282.14%--
Return on Assets (ROA)
-24.28%-9.61%-6.51%-
Return on Capital Employed (ROCE)
-84.60%-16.20%10.50%-69.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-9.98%-10.83%--
FCF Yield
-5.76%0.76%--
Buyback Yield / Dilution
-259.84%-714.45%--